In that study, we observed significantly lower levels of BMP-6 mRNA in ER- breast cancer cells compared with ER+ breast cancer cells, an effect attributed to hypermethylation status in the ER- breast cancer cells [48]. The gene discussed is BMP6; the disease is breast cancer.